INS and edema: Exendin-4, a GLP1 receptor agonists, was found to improve pulmonary edema, oxidative stress and lung injury in diabetic mice. Exendin-4 decreased hyperglycemic lung damage by reducing glucose-mediated oxidative stress. It was also found to increase lung injury by decreasing insulin signaling in the lungs.